ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Design, Synthesis and Biological Activity of Low-Molecular-Weight URAT1 Inhibitors

Chen, Siliang; Chen, Ya; Yang, Zhongcheng; Huang, Wanqiu; Cao, Zhijun; Wang, Xuekun; Yao, Huixin; Li, Zheng*; Wang, Guangji*广东药学院; 1
ChemistrySelect2023-2-3DOI: 10.1002/slct.202204440
6阅读
引用收藏
分享

摘要

Hyperuricemia has become a global problem and is one of the four basic metabolic diseases after hypertension, hyperlipidemia, and hyperglycemia. However, the existing drugs have undesired or serious adverse effects, such as the high risk of Stevens-Johnson syndrome for allopurinol, and the cardiovascular side effects induced by febuxostat. Therefore, it is an urgent need to develop an effective and safety agent for the treatment of hyperuricemia. The urate transporter 1 (URAT1) inhibitors have been considered as a promising uric acid-lowering agents. To improve adverse reactions caused by excessive lipophilicity and large molecular weight of existing drugs, five novel low-molecular- weight URAT1 Inhibitors were designed and synthesized by molecular hybridisation. Among them, although compound 4 showed less potent activity than the classic URAT1 inhibitor benzbromarone in vitro, compound 4 exhibited better uric acid-lowering activity than benzbromarone in vivo, which may be related to the fact that compound 4 has lower lipophilicity than benzbromarone to facilitate drug absorption. In addition, compound 4 cherishes some merits, which have a smaller molecular weight and lower lipophilicity, and superior in vitro activity than lesinurad. Generally, the results indicate that compound 4, with a good therapeutic effect, is a prospective candidate for the treatment of hyperuricemia.

学科与关键词

关键词
HyperuricemiaLow molecular weightLower lipophilicityURAT1 inhibitor
相关
加载中…
  • Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents
    Zhao, Zean; Liu, Jin; Yuan, Lin; Yang, Zichao; Kuang, Peihua; Liao, Hui; Luo, Jian; Feng, Huancun; Zheng, Fengxin; Chen, Yongjun; Wu, Ting; Guo, Jiayin; Cao, Ying; Yang, Yang; Lin, Cuiting; Zhang, Qun*; Chen, Jianjun*; Pang, Jianxin*European Journal of Medicinal Chemistry, 2022, 242: 114682.被引 3
  • Design, synthesis, and biological studies of dual URAT1 inhibitor and FXR agonist based on benzbromarone
    Huang, Wanqiu; Jiao, Shixuan; Chen, Siliang; Chen, Ya; Yang, Zhongcheng; Wang, Wenxin; Cao, Zhijun; Li, Zheng; Zhang, Luyong*Bioorganic and Medicinal Chemistry, 2022, 75: 117073.
  • Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitors
    Zhang, Jian; Dong, Yue; Gao, Shenghua; Zhang, Xujie; Liao, Hui; Shi, Xiaoyu; Zhang, Zhijiao; Zhao, Tong; Liang, Ruipeng; Qi, Danhui; Wu, Ting*; Pang, Jianxin*; Liu, Xinyong*; Zhan, Peng*European Journal of Medicinal Chemistry, 2022, 244: 114816.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
ChemistrySelect
发表日期
2023-02-03
卷期
第 8 卷, 第 5 期
DOI
10.1002/slct.202204440
成果收录
SCIE
资助标注
Basic and Applied Basic Research of Guangzhou [202201010436]; National Key Clinical Specialty Construction Project; High-Level Clinical Key Specialty (Clinical Pharmacy) in Guangdong Province; Special Fund of Science and Technology Innovation cultivation Project of Guangdong University students [pdjh2022a0262]; Open Project of Guangxi Key Laboratory of Precision Medicine [202110573005]; Innovation and Entrepreneurship Training program for College students; [GXXNXG202101]

作者

  • C

    Chen, Siliang (第一作者)

    guangdong pharmaceut univ · 1

  • C

    Chen, Ya

    1 · guangdong pharmaceut univ

查看全部 9 位作者收起作者
  • Y

    Yang, Zhongcheng

    guangdong pharmaceut univ

  • H

    Huang, Wanqiu

    guangdong pharmaceut univ

  • C

    Cao, Zhijun

    guangdong pharmaceut univ · new

  • W

    Wang, Xuekun

    liaocheng univ

  • Y

    Yao, Huixin

    guangdong pharmaceut univ

  • L

    Li, Zheng (通讯)

    guangdong pharmaceut univ · 1 · new

  • W

    Wang, Guangji (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417